SCM
HAE icon

Suffolk Capital Management’s Haemonetics HAE Stock Holding History

Suffolk Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$408K Sell
4,077
-4,905
-55% -$515K 0.08% 62
2018
Q3 		$1.03M Sell
8,982
-573
-6% -$59.3K 0.15% 56
2018
Q2 		$857K Sell
9,555
-3,210
-25% -$271K 0.12% 79
2018
Q1 		$934K Buy
+12,765
New +$876K 0.13% 64

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Suffolk Capital Management's HAE Position: Q4 2018 in Review

Suffolk Capital Management reduced its Haemonetics (HAE) stake by 55% in Q4 2018, selling an estimated $515K and leaving 4,077 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #62.

Suffolk Capital Management first reported a position in HAE in Q1 2018 and has held it in 4 quarters since. The position peaked at $1.03M in Q3 2018. 279 funds tracked by Wall St. Rank hold HAE as of Q4 2018.

  • Suffolk Capital Management held 4,077 shares of Haemonetics worth $408K as of Q4 2018.
  • Suffolk Capital Management sold 4,905 Haemonetics shares in Q4 2018, an estimated $515K.
  • Haemonetics made up 0.08% of Suffolk Capital Management's portfolio in Q4 2018, its #62 holding.
  • Suffolk Capital Management first reported a position in Haemonetics in Q1 2018 and has held it in 4 quarters since.
  • Suffolk Capital Management's Haemonetics position peaked at $1.03M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held Haemonetics as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.